Please login to the form below

Not currently logged in
Email:
Password:

Bulgarian pharma industry to strike over price cuts

The Bulgarian pharmaceutical industry is poised to strike over proposed price decreases in the new regulations for the registration and prices of medication

The Bulgarian pharmaceutical industry is poised to strike over proposed price decreases in the new regulations for the registration and prices of medication, according to local media reports.

The Bulgarian Pharmaceutical Union (BFU) claimed in an 11 November announcement on Bulgarian National Radio that lower prices would lead to the bankruptcy of pharmacies.

Head of the Pharmaceutical Group of the European Union (PGEU), Leopold Schmudermaier, will visit Bulgaria on 24 November for a special conference of the BFU, the union revealed.

Schmudermaier had sent an open letter to the Bulgarian health ministry, which criticised the new regulation. He claimed that lower prices would lead to lower quality pharmaceutical services and problematic access to medication for patients because of bankruptcies of pharmacies, caused by the proposed price decreases.

The BFU said in a press statement that it was categorically against the proposed cut in surplus charges for pharmacies over the distribution and sales of medication.

It added: "At the November BFU conference, rules and regulations for good pharmaceutical practise were set. Following these rules would become impossible, if Parliament accepts the current proposal, as pharmacies would not be able to afford to do so."

30th September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
ABPI2018
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....

Infographics